Abbott Laboratories (ABT) Q2 2009 Earnings Results

Abbott Labs Beats on EPS, Stock Down N/A%

Abbott Labs reported a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and no guidance may lead to uncertainty among investors. The stock reaction is not available, but the cautious tone from management suggests they are navigating a challenging market environment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.89	N/A	+0.56%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a cautious optimism about the company's performance. They acknowledged market challenges while emphasizing their commitment to innovation.

Management expressed satisfaction with the EPS performance despite the lack of revenue data.

They noted ongoing challenges in the market but highlighted strong product demand.

Abbott Labs Beats on EPS, Stock Down N/A%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Beats on EPS, Stock Down N/A%

Key numbers

Management commentary